Na(+) and Ca(2+) homeostasis pathways, cell death and protection after oxygen-glucose-deprivation in organotypic hippocampal slice cultures

Neuroscience. 2004;128(4):729-40. doi: 10.1016/j.neuroscience.2004.06.074.

Abstract

Intracellular ATP supply and ion homeostasis determine neuronal survival and degeneration after ischemic stroke. The present study provides a systematic investigation in organotypic hippocampal slice cultures of the influence of experimental ischemia, induced by oxygen-glucose-deprivation (OGD). The pathways controlling intracellular Na(+) and Ca(2+) concentration ([Na(+)](i) and [Ca(2+)](i)) and their inhibition were correlated with delayed cell death or protection. OGD induced a marked decrease in the ATP level and a transient elevation of [Ca(2+)](i) and [Na(+)](i) in cell soma of pyramidal neurons. ATP level, [Na(+)](i) and [Ca(2+)](i) rapidly recovered after reintroduction of oxygen and glucose. Pharmacological analysis showed that the OGD-induced [Ca(2+)](i) elevation in neuronal cell soma resulted from activation of both N-methyl-d-aspartate (NMDA)-glutamate receptors and Na(+)/Ca(2+) exchangers, while the abnormal [Na(+)](i) elevation during OGD was due to Na(+) influx through voltage-dependent Na(+) channels. In hippocampal slices, cellular degeneration occurring 24 h after OGD, selectively affected the pyramidal cell population through apoptotic and non-apoptotic cell death. OGD-induced cell loss was mediated by activation of ionotropic glutamate receptors, voltage-dependent Na(+) channels, and both plasma membrane and mitochondrial Na(+)/Ca(2+) exchangers. Thus, we show that neuroprotection induced by blockade of NMDA receptors and plasma membrane Na(+)/Ca(2+) exchangers is mediated by reduction of Ca(2+) entry into neuronal soma, whereas neuroprotection induced by blockade of AMPA/kainate receptors and mitochondrial Na(+)/Ca(2+) exchangers might result from reduced Na(+) entry at dendrites level.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Animals
  • Animals, Newborn
  • Boron Compounds / pharmacology
  • Calcium / metabolism*
  • Calcium Channel Blockers / pharmacology
  • Cell Death / physiology*
  • Clonazepam / analogs & derivatives*
  • Clonazepam / pharmacology
  • Dantrolene / pharmacology
  • Dizocilpine Maleate / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Excitatory Amino Acid Antagonists / pharmacology
  • Fura-2 / metabolism
  • Glucose / deficiency*
  • Hippocampus / cytology*
  • Hippocampus / metabolism
  • Hypoxia*
  • In Situ Nick-End Labeling / methods
  • Indoles / pharmacology
  • Intracellular Space / metabolism
  • Ion Exchange
  • Lidocaine / pharmacology
  • Mibefradil / pharmacology
  • Nimodipine / pharmacology
  • Organ Culture Techniques
  • Quinoxalines / pharmacology
  • Rats
  • Rats, Wistar
  • Sodium / metabolism*
  • Sodium Channel Blockers / pharmacology
  • Thiazepines / pharmacology
  • Thiourea / analogs & derivatives*
  • Thiourea / pharmacology
  • Time Factors

Substances

  • 2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate
  • Boron Compounds
  • Calcium Channel Blockers
  • Enzyme Inhibitors
  • Excitatory Amino Acid Antagonists
  • Indoles
  • Quinoxalines
  • Sodium Channel Blockers
  • Thiazepines
  • 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline
  • Mibefradil
  • Nimodipine
  • Clonazepam
  • Dizocilpine Maleate
  • CGP 37157
  • Adenosine Triphosphate
  • Lidocaine
  • Sodium
  • 2-aminoethoxydiphenyl borate
  • Dantrolene
  • Thiourea
  • Glucose
  • Calcium
  • Fura-2
  • cyclopiazonic acid